Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2025 published in Newspaper.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Resonance Specialties Limited (BSE Scrip Code 524218) published its unaudited Q2 and H1 FY26 financial results in Business Standard (all editions) and Nav Shakti (Marathi) on November 4, 2025, as approved at the Board Meeting on November 3, 2025. Total income from operations for Q2 FY26 rose to Rs. 2,153.35 lakhs from Rs. 1,806.45 lakhs in Q2 FY25, a growth of about 19%. However, Q2 net profit after tax dipped slightly to Rs. 165.70 lakhs from Rs. 180.52 lakhs, and Q2 EPS stood at Rs. 1.44 vs Rs. 1.56. For the half year, total income climbed to Rs. 4,280.77 lakhs from Rs. 3,536.67 lakhs, while net profit after tax grew strongly to Rs. 328.74 lakhs from Rs. 239.32 lakhs (~37% growth), with H1 EPS at Rs. 2.85. The company operates in the Chemical Manufacturing segment, with both domestic (Rs. 2,005.94 lakhs) and export (Rs. 2,274.83 lakhs) revenue contributing to H1 growth.
This is a routine newspaper publication of already-approved quarterly results, so no new information is being disclosed. The strong H1 profit growth is positive, but the modest Q2 profit decline despite revenue growth may draw investor attention to margins.